Neuroendocrine Tumors of the Thymus

Thoracic Surgery Clinics

Volumn 21, Issue 1, 2011, Pages 13-23

  Ruffini, Enrico ^a   Oliaro, Alberto ^a   Novero, Domenico ^a   Campisi, Paola ^a   Filosso, Pier Luigi ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Mediastinum; Neuroendocrine tumors; Pathology; Surgery; Thymus

Indexed keywords

ALPHA INTERFERON; OCTREOTIDE; PENTETREOTIDE; SUNITINIB;

CANCER CLASSIFICATION; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOLOGY; MEDIASTINUM CANCER; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THORAX RADIOGRAPHY; THYMOMA; TUMOR DIFFERENTIATION;

COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; KERATINS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; PROGNOSIS; THYMUS NEOPLASMS;

EID: 78149446564     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2010.08.013     Document Type: Review

References (52)

1. Rosai J., Higa E. Mediastinal endocrine neoplasm of probable thymic origin related to carcinoid tumor. Cancer 1972, 29:1061-1074.
2. Wick M.R., Scott R.E., Li C.Y., et al. Carcinoid tumor of the thymus: a clinicopathologic report of seven cases with a review of the literature. Mayo Clin Proc 1980, 55:246-254.
3. Moran C.A., Suster S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus: a clinicopathologic analysis of 80 cases. Am J Clin Pathol 2000, 114:100-110.
4. Oberg K., Jelic S. Neuroendocrine bronchial and thymic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up. Ann Oncol 2008, 19:ii102-ii103.
5. Wick M.R., Scheithauer B.W., Weiland L.H., et al. Primary mediastinal carcinoid tumors. Am J Surg Pathol 1982, 6:195-205.
6. Economopoulos G.C., Lewis J.W., Lee M.W., et al. Carcinoid tumors of the thymus. Ann Thorac Surg 1990, 50:58-61.
7. Valli M., Fabris G.A., Dewar A., et al. Atypical carcinoid tumour of the thymus: a study of eight cases. Histopathology 1994, 24:371-375.
8. Wang D.Y., Chang D.B., Kuo S.H., et al. Carcinoid tumours of the thymus. Thorax 1994, 49:357-360.
9. de Montpreville V.T., Macchiarini P., Dulmet E. Thymic neuroendocrine carcinoma (carcinoid): a clinicopathologic study of fourteen cases. J Thorac Cardiovasc Surg 1996, 111:134-141.
10. Fukai I., Masaoka A., Fujii Y., et al. Thymic neuroendocrine tumor (thymic carcinoid): a clinicopathologic study in 15 patients. Ann Thorac Surg 1999, 67:208-211.
11. Gal A.A., Kornstein M.J., Cohen C. Neuroendocrine tumors of the thymus: a clinicopathologic and prognostic study. Ann Thorac Surg 2001, 72:1179-1182.
12. de Perrot M., Spiliopoulos A., Fisher S., et al. Neuroendocrine carcinoma (carcinoid) of the thymus associated with Cushing's syndrome. Ann Thorac Surg 2002, 73:675-681.
13. Tiffet O., Nicholson A.G., Ladas G., et al. A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus. Chest 2003, 124:141-146.
14. Cardillo G., Treggiari S., Paul M.A., et al. Primary neuroendocrine tumours of the thymus: a clinicopathologic and prognostic study in 19 patients. Eur J Cardiothorac Surg 2010, 37:814-818.
15. Klemm K.M., Moran C.A. Primary neuroendocrine carcinomas of the thymus. Semin Diagn Pathol 1999, 16:32-41.
16. Verley J.M., Hollmann K.H. Tumours of the mediastinum. Current histopathology 1992, vol. 19:102-108. Kluwer Academic, London. G.A. Gresham (Ed.).
17. Chaer R., Massad M.G., Evans A., et al. Primary neuroendocrine tumors of the thymus. Ann Thorac Surg 2002, 74:1733-1740.
18. Van Brandt V., Heymann S., Van Marck E., et al. Atypical presentation of an atypical carcinoid. Ann Thorac Surg 2009, 88:2004-2006.
19. John L., Hornick P., Lang S., et al. Giant thymic carcinoid. Postgrad Med J 1991, 67:462-465.
20. Dusmet M.E., McKneally M.F. Pulmonary and thymic carcinoid tumors. World J Surg 1996, 20:189-195.
21. Rosado de Christenson M.L., Abbott G.F., Kirejczky W.M. Thoracic carcinoids: radiologic-pathologic correlations. Radiographics 1999, 19:707-711.
22. Filosso P.L., Actis dato G.M., Ruffini E., et al. Multidisciplinary treatment of advanced thymic neuroendocrine carcinoma (carcinoid): report of a successful case and review of the literature. J Thorac Cardiovasc Surg 2004, 127:1215-1219.
23. Lastoria S., Vergara E., Palmieri G., et al. In vivo detection of malignant thymic masses by Indium-111-DTPA-d-pentetreotide scintigraphy. J Nucl Med 1998, 39:634-639.
24. Cadigan D.G., Hollett P.D., Collingwood P.W., et al. Imaging of mediastinal thymic carcinoid tumor with radiolabelled somatostatin analogue. Clin Nucl Med 1996, 21:487-488.
25. Groves A.M., Mohan H.K., Wegner E.A., et al. Positron emission tomography with FDG to show thymic carcinoid. AJR Am J Roentgenol 2004, 182:511-513.
26. Duh Q.Y., Hybarger C.P., Geist R., et al. Carcinoids associated with multiple endocrine neoplasia syndromes. Am J Surg 1987, 154:142-158.
27. Arrigoni M.G., Woolner L.B., Bernatz P.E. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 1972, 64:413-421.
28. Teh B.T. Thymic carcinoid tumors in multiple endocrine neoplasia type 1. J Intern Med 1998, 243:501-504.
29. Levine G.D., Rosai J. Thymic hyperplasia and neoplasia. A review of current concepts. Hum Pathol 1978, 9:295-514.
30. Marchevsky A.M., Dikman S.H. Mediastinal carcinoid with an incomplete Sipple's syndrome. Cancer 1979, 43:2497-2501.
31. Wick M.R., Rosai J. Neuroendocrine neoplasms of the thymus. Pathol Res Pract 1988, 183:188-199.
32. Lowenthal R.M., Gumpel J.M., Kreel L., et al. Carcinoid tumor of the thymus with systemic manifestations: a radiological and pathological study. Thorax 1974, 92:553-558.
33. Wu MH;Tseng Y.L., Cheng F.F., Lin T.S. Thymic carcinoid combined with myasthenia gravis. J Thorac Cardiovasc Surg 2004, 127:584-585.
34. Liu H.C., Hsu W.H., Chen Y.J., et al. Primary thymic carcinoma. Ann Thorac Surg 2002, 73:1076-1081.
35. Marx A., Shimosato Y., Kuo T.T., et al. Thymic neuroendocrine tumours. WHO classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart 2004, 188-195. IARC Press, Lyon (France). W.D. Travis, E. Brambilla, H.K. Muller-Hermelink (Eds.).
36. Suster S., Moran C.A. Neuroendocrine neoplasms of the mediastinum. Am J Clin Pathol 2001, 115(Suppl):S17-S27.
37. Moran C.A. Primary neuroendocrine carcinomas of the mediastinum: review of current criteria for histopathologic diagnosis and classification. Semin Diagn Pathol 2005, 22(3):223-229.
38. Wakely P.E. Cytopathology-histopathology of the mediastinum II. Mesenchymal, neural, and neuroendocrine neoplasms. Ann Diagn Pathol 2005, 9(1):24-32.
39. Masaoka A., Monden Y., Nakahara K., et al. Follow-up study of thymoma with special reference to their clinical stages. Cancer 1981, 48:2485-2492.
40. Koga K., Matsuno Y., Noguchi M., et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 1994, 44(5):359-367.
41. Huang J., Riely G.J., Rosenzweig K.E., et al. Multimodality therapy for locally invasive thymomas: state of the art or investigational therapy?. Ann Thorac Surg 2008, 85:365-367.
42. Huang J., Rizk N.P., Travis W.D., et al. Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg 2007, 134:1477-1484.
43. Zeiger M.A., Swartz S.E., MacGillivray D.C., et al. Thymic carcinoid in association with MEN syndromes. Am J Surg 1992, 58:430-434.
44. Trump D., Farren B., Wooding C., et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN-1). QJM 1996, 89:653-669.
45. Dham A., Truskinovsky A.M., Dudek A.Z. Thymic carcinoid responds to neoadjuvant therapy with sunitinib and octreotide: a case report. J Thorac Oncol 2008, 3:94-97.
46. Hage R., de la Rivière A.B., Seldenrijk C.A., et al. Update in pulmonary carcinoid tumors. A review article. Ann Surg Oncol 2003, 10:697-704.
47. Kosmidis P.A. Treatment of carcinoid of the lung. Curr Opin Oncol 2004, 16:146-149.
48. Oberg K., Norheim I., Theodorsson E. Treatment of malignant midgut carcinoid tumors with a long acting somatostatin analogue octreotide. Acta Oncol 1991, 30:503-507.
49. Teh B.T., McArdle J., Chan S.P., et al. Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1. Medicine 1997, 76:21-29.
50. Ferolla P., Falchetti A., Filosso P.L., et al. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab 2005, 90:2603-2609.
51. Sakuragi T., Rikitake K., Nastuaki M., et al. Complete resection of recurrent thymic carcinoid using cardiopulmonary bypass. Eur J Cardiothorac Surg 2002, 21:152-154.
52. Slooter G.D., Breenan W.A., Marqnet R.L., et al. Anti-proliferative effect of radiolabeled octreotide in a metastases model in rat liver. Int J Cancer 1999, 81:767-771.